Pramipexole is a useful adjunct to mood-stabilising therapy in treatment-resistant bipolar depression

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1430, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atypical antipsychotics may be useful as adjuncts to antidepressant therapy in treatment-resistant depression

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

By Singh Jaskaran Zarate Carlos Krystal Andrew

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 227-228

Springer Publishing Company

Access to resources Recommend Favorite

Lamotrigine In Adolescent Treatment–Resistant Depression

Child and Adolescent Psychopharmacology News, Vol. 11, Iss. 2, 2006-05 ,pp. : 1-10

Guilford Publications Inc

Access to resources Recommend Favorite

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 656-662

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Approaches for Treatment-resistant Bipolar Disorder

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 592-604

Bentham Science Publishers

Access to resources Recommend Favorite